Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Dec;2(12):1307-13.
doi: 10.18632/oncotarget.396.

Finding cancer's weakest link

Nicole M Sodir  1 , Gerard I Evan
Affiliations
Review

Finding cancer's weakest link

Nicole M Sodir et al. Oncotarget. 2011 Dec.

Abstract

The biological programs of vertebrates exhibit a remarkable degree of functional degeneracy, adaptive compensation and robustness, to preserve homeostasis and generate reproducible phenotypic outputs irrespective of variations in signal strength, noise and quality. Cancers are difficult to treat not only because they are so mechanistically diverse but also because they adapt or evolve in response to any pharmacological elective pressure we impose upon them. Hence, an ideal cancer drug target would exert a function both necessary for cancer cell survival and functionally non-redundant, rendering it impossible for tumor cells to compensate for, or evolve independence from, the inhibitory effect of any drug aimed at that target. In this review, we discuss the unique, non-degenerate and highly pleiotropic role played by Myc in coordinating, engaging and maintaining the diverse intracellular and extracellular programs required for cell proliferation in vivo. These properties make Myc a compelling candidate cancer drug target, at least in principle: an assertion recently reinforced by new in vivo genetic data.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Schematic model of how the need for robustness in biological systems is reconciled with the need for binary switchability
The consolidated outputs from robust, self-correcting and functionally degenerate information-gathering and information-processing “clouds” (e.g. receptor tyrosine kinases, intracellular kinases, disparate coordinated programs mediating somatic cell replication and propagation) are hypothesized to funnel down into functionally non-degenerate, go/no go switches such Ras, Myc and the activating E2F (E2F1, 2 & 3a) proteins. The obligate and functionally non-degenerate properties of Myc, Ras and E2F make them a unique class of therapeutic drug target, whose inhibition cannot easily be circumvented by compensatory or evolutionary mechanisms. However, the very essentialness of these targets raises the specter of severe side effects. In this regard, Myc has the advantage that, since its sole biological role appears to be in cell proliferation, the only side effects of Myc inhibition are likely to affect regenerating tissues.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008;8(8):592–603. - PMC - PubMed
    1. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295(5564):2387–2392. - PubMed
    1. Fingleton B. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects. Expert Opin Ther Targets. 2003;7(3):385–397. - PubMed
    1. Miller KD, Sweeney CJ, Sledge GW., Jr. Can tumor angiogenesis be inhibited without resistance? EXS. 2005;(94):95–112. - PubMed
    1. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev. 2008;22(20):2755–2766. - PMC - PubMed

Substances

LinkOut - more resources